Armistice Capital
$3.0B 13F equity value
455 Holdings
Latest filing 2026-03-31
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| TVTX | TRAVERE THERAPEUTICS INC | 4,897,417 | $146M | 4.8% |
| PTCT | PTC THERAPEUTICS INC | 2,074,449 | $141M | 4.7% |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 264,583 | $139M | 4.6% |
| SUPN | SUPERNUS PHARMACEUTICALS | 1,895,347 | $98M | 3.2% |
| NBIX | NEUROCRINE BIOSCIENCES INC | 724,000 | $95M | 3.1% |
| AGIO | AGIOS PHARMACEUTICALS INC | 2,716,000 | $92M | 3.0% |
| IMVT | IMMUNOVANT INC | 3,564,916 | $89M | 2.9% |
| FRPT | FRESHPET INC | 1,093,307 | $64M | 2.1% |
| INCY | INCYTE CORP | 656,817 | $62M | 2.0% |
| DYN | DYNE THERAPEUTICS INC | 3,175,110 | $58M | 1.9% |
Track Armistice Capital's 13F portfolio: $3.0B in reported holdings, 455 positions. Top holdings and quarterly changes on SentiSense.